We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Intramuscular Adipose Tissue Accumulation as a Key Determinant of Muscle Dysfunction in Peripheral Artery Disease

MedXY Editorial Team•Mar 10, 2026•Cardiology
CLTIPeripheral Artery Disease

Highlights

  • Chronic limb-threatening ischemia (CLTI) is characterized by a distinct adipogenic and fibrotic muscular phenotype compared to mild peripheral artery disease (PAD).
  • The accumulation of intramuscular adipose tissue (IMAT) is negatively correlated with muscle strength and work output in both human subjects and murine models.
  • Fibroadipogenic progenitor cells (FAPs) are the cellular source of IMAT in ischemic muscle, and their adipogenic potential is regulated by Pparγ signaling.
  • Genetic or pharmacological inhibition of IMAT formation significantly improves limb function, offering a potential non-revascularization strategy for PAD patients.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Comparing Endovascular and Surgical Revascularization Outcomes in Claudication Due to Femoropopliteal Disease: Insights from Medicare-Linked DataThis study compares long-term outcomes of endovascular versus open bypass interventions for femoropopliteal disease in patients with claudication, finding similar rates of major adverse limb events and progression to critical limb ischemiaSep 17, 2026Harnessing Genetic Insights: Polygenic Risk Score Enhances Prediction of Peripheral Artery Disease and Limb EventsA validated polygenic risk score (PRS) independently predicts peripheral artery disease (PAD) and major adverse limb events (MALE) in patients with cardiometabolic disease, adding modest but significant predictive value beyond traditional cSep 6, 2026Bempedoic Acid Significantly Reduces Limb and Cardiovascular Events in Statin-Intolerant Patients with Peripheral Artery Disease: Insights from the CLEAR Outcomes TrialBempedoic acid reduces the risk of major adverse limb and cardiovascular events in statin-intolerant patients with peripheral artery disease, illustrating its potential to enhance vascular risk management.Aug 22, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Declining Use But Persistent Readmissions: A National Analysis of Open Lower Extremity Revascularization OutcomesThis national study identifies key factors linked to 30-day nonelective readmissions after open lower extremity revascularization, highlighting stable readmission rates despite reduced procedure volume and the need for standardized dischargAug 19, 2026
Peripheral Artery Disease: Emerging Advances in Medical Therapy to Reduce Cardiovascular and Limb RisksThis article reviews recent advances in the medical management of peripheral artery disease, emphasizing comprehensive risk factor control, novel pharmacotherapies, and individualized approaches to improve cardiovascular and limb outcomes iJul 18, 2026
Drug-Eluting Resorbable Scaffold Maintains a 3-Year Patency Advantage Over Angioplasty in Infrapopliteal CLTIThree-year LIFE-BTK data show sustained patency and reintervention benefits with a drug-eluting resorbable scaffold versus angioplasty in selected patients with infrapopliteal CLTI, with comparable limb salvage and safety.May 15, 2026